Zobrazeno 1 - 8
of 8
pro vyhledávání: ''
Autor:
Verena Fourkiotis, Oliver Vonend, Sven Diederich, Evelyn Fischer, Katharina Lang, Stephan Endres, Felix Beuschlein, Holger S Willenberg, Lars C Rump, Bruno Allolio, Martin Reincke, Marcus Quinkler
Publikováno v:
European Journal of Endocrinology. 168:75-81
ObjectivePrimary aldosteronism (PA) has deleterious effects on kidney function independent of blood pressure levels. Up to now, data on effectiveness of different PA therapies regarding renal function are scarce.Design and methodsThis prospective mul
Publikováno v:
European Journal of Endocrinology. 157:75-83
Objective: We evaluated the respective value of insulin, C-peptide and proinsulin levels in 33 patients with endogenous hyperinsulinism and in 67 controls to determine the best parameters and thresholds to make or to rule out the diagnosis of endogen
Autor:
Dorthe Cartier, Antoine Bennet, C. Regnier, Monique Plantavid, P. Caron, Françoise Parmentier, André Lacroix, Hervé Lefebvre, Delphine Vezzosi, Ph. Otal
Publikováno v:
European Journal of Endocrinology. 156:21-31
ACTH-independent macronodular adrenocortical hyperplasia (AIMAH) is rare and generally presents as a sporadic disease. We describe a familial case of AIMAH with in vivo and in vitro demonstration of aberrant 5-HT4 and vasopressin adrenal receptors. T
Publikováno v:
European Journal of Endocrinology. 154:519-524
Objectives: To evaluate the efficacy of fluconazole as an alternative treatment for controlling hypercortisolism in Cushing’s syndrome and to determine its effect on glucocorticoid production in vitro. Design: Case report and in vitro study in a Un
Autor:
Giuseppe Reimondo, Massimo Mannelli, Giuseppe Opocher, Franco Mantero, Massimo Terzolo, Alberto Angeli, Anna Pia, Chiara Dall'Asta, Bruno Ambrosi, Silvia Bovio, Pier Antonio Conton, Donatella Bemporad
Publikováno v:
European Journal of Endocrinology. 153:307-315
Objective: There is scant information on the morbidity associated with subclinical Cushing’s syndrome in patients with a clinically inapparent adrenal adenoma. In the present study, we have determined the prevalence of alterations of the hypothalam
Autor:
G Pagani, Alberto M Pedroncelli, Kris Poppe, Dominique Maiter, JJ Legros, D. Gianola, G Albani, Jean Mockel, Marie Bex, M. Montini, Mark Vandeweghe, Roger Abs, Pagani, J. Verhelst
Publikováno v:
Scopus-Elsevier
OBJECTIVE: Slow-release (SR) lanreotide is a long-acting somatostatin analog that has been developed in order to overcome the inconvenience of multiple daily subcutaneous injections of octreotide, required for metabolic control in acromegaly. Lanreot
Publikováno v:
European Journal of Endocrinology. :238-245
OBJECTIVE: An increased response of 17-hydroxyprogesterone to ACTH stimulation has been observed in adrenal incidentaloma and linked to an impairment of either 21-hydroxylase or of 11beta-hydroxylase activity. To analyse this question further, we inv
Autor:
William Drake, Scott Akker, Ashley B. Grossman, Hazel Finney, Shern L. Chew, Michel Procopiou, Jacky M. Burrin
Publikováno v:
European Journal of Endocrinology. 161:509
ObjectiveTo define the test characteristics of an enzyme immunoassay (EIA) for plasma-free metanephrines (metanephrine and normetanephrine) in the diagnosis of pheochromocytoma and paraganglioma.DesignProspective observational design from a single Un